Learn More
Chembio Procise IFX Assay Infliximab

Description
- Quantitative TDM for Infliximab: Enables rapid measurement of infliximab levels in serum to support therapeutic management of IBD patients
- Fast Results: Delivers accurate, quantitative results in under 5 minutes using the ProciseDx™ Analyzer
- Validated for Clinical Use: FDA-cleared for use in moderate-complexity labs; supports both adult and pediatric Crohn's disease and ulcerative colitis care
- Proven Analytical Performance: Sensitive and specific TR-FRET-based immunoassay with a reportable range of 1.2 to 50 μg/mL
- Simple Workflow: Uses standard serum samples and minimal hands-on time
Specifications
Specifications
| Certifications/Compliance | FDA DeNovo |
| Content And Storage | 15°C to 30°C (59°F to 86°F) |
| Control Sets | Included High and Low |
| CE Marker | Yes |
| Clia Complexity | Moderate (Prescription Use Only) |
| Detectable Analytes | Infliximab |
| Detection Method | Measures Relative Fluorescence Units (RFU) |
| DoA Calibrators | No |
| Sample Type | Serum |
| Type | Test Cartridge |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.